Michael Chi - 07 Mar 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Signature
/s/ Kimberly Mather, Attorney-in-Fact for Michael Chi
Issuer symbol
HIMS
Transactions as of
07 Mar 2025
Net transactions value
-$108,171
Form type
4
Filing time
25 Sep 2025, 18:06:50 UTC
Previous filing
05 Mar 2025
Next filing
18 Mar 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chi Michael Chief Commercial Officer 2269 CHESTNUT STREET, #523, SAN FRANCISCO /s/ Kimberly Mather, Attorney-in-Fact for Michael Chi 25 Sep 2025 0001965903

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Gift $0 -5,700 -1.9% $0.000000 291,439 07 Mar 2025 Direct F1
transaction HIMS Class A Common Stock Options Exercise $10,521 +2,100 +0.72% $5.01 293,539 24 Sep 2025 Direct F2
transaction HIMS Class A Common Stock Sale $118,692 -2,100 -0.72% $56.52 291,439 24 Sep 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -2,100 -1.2% $0.000000 174,042 24 Sep 2025 Class A Common Stock 2,100 $5.01 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares represent a gift to a Donor Advised Fund.
F2 The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.
F3 The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.